Search - tctmd.com

Displaying 941 - 960 of 1334

Sort: Relevancy | Date

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

November 20, 2012

Presentation

Evaluating the Impact of Public Health Notification: Duke Clopidogrel Experience

Presenter: Eric L. Eisenstein

November 19, 2012

Presentation

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Presenter: A. Sachdeva

November 13, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News AHA 2012

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

November 04, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Conference News TCT 2012

Postconditioning Fails to Improve Outcomes in STEMI Patients Over Primary PCI Alone

October 26, 2012

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

News Conference News TCT 2012

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

October 25, 2012

News Industry News

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

October 25, 2012

Presentation TCT 2012

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

Presenter: Michael Love

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

Advertisement

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

Estudio muestra el impacto de la comunicación de salud pública en el uso de clopidogrel después de la colocación de un SLF

Evaluating the Impact of Public Health Notification: Duke Clopidogrel Experience

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Stroke Prevention Strategies Discussed

Postconditioning Fails to Improve Outcomes in STEMI Patients Over Primary PCI Alone

Two Trials Examine Device-Based PFO Closure

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content